NEW YORK, April 12, 2016 /PRNewswire/ -- The life sciences BPO market comprises services offered by CMOs (Contract Manufacturing Organizations) and CROs (Contract Research Organizations) to the biotech pharmaceutical companies. A rise in demand for low cost drugs, patent expirations and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This support has facilitated pharma players to streamline their value chain and focus more on its core strategies.
Each of the segments has been analyzed in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global life sciences BPO market and could influence the market in the future as well. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition between leading market players operating across the globe. Porter's five forces analysis is also explained in this section to understand the market considering different parameters that have an impact on the sustainability of the companies operating in the market. Additionally, a detailed value chain analysis for different components of the CRO and CMO have been covered to provide a comprehensive view of the industry. The report also mentioned about leading players for each of the sub-segments such as clinical trial, API manufacturing, vaccines, injectable among others.
All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their respective market shares. The recommendations section included in the report would assist existing market players in targeting all major stake holders of this industry such as companies, payers, providers, patients, government agencies and also to those aiming to seek an entry. The report also profiles major players in the global life sciences BPO market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments.
Key players in the life sciences BPO market include: Accenture plc, Anthelio Healthcare Solutions, Boehringer Ingelheim GmbH, Catalent, Inc., Cognizant Technology Solutions, Covance, Inc. Genpact Limited, ICON plc, Infosys Limited, International Business Machines Corporation, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, and Wipro Limited.
The Global Life Sciences BPO market has been segmented as follows:
Global Life Sciences BPO Market, by Services
Contract Research Organizations
Clinical Data Management
Contract Manufacturing Organizations
Active Pharmaceutical Ingredients
Finished Dose Form Manufacturing
Contract Sales and Marketing Organizations
Others (Payers and Providers)
Global Life Sciences BPO Market, by Geography
Rest of the Europe
Rest of the World
Middle East and Africa
Read the full report: http://www.reportlinker.com/p03516816-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/life-sciences-bpo-market-contract-manufacturing-organizations-contract-sales-and-marketing-organizations-and-others---global-industry-analysis-size-share-growth-trends-and-forecast-2015---2023-300249298.html